5‐Hydroxymethylcytosine as a clinical biomarker: Fluorescence‐based assay for high‐throughput epigenetic quantification in human tissues-Reference-Cited by-同舟云学术

5‐Hydroxymethylcytosine as a clinical biomarker: Fluorescence‐based assay for high‐throughput epigenetic quantification in human tissues

Published:2019-07-02 Issue:1 Volume:146 Page:115-122
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Margalit Sapir¹,Avraham Sigal¹,Shahal Tamar¹,Michaeli Yael¹,Gilat Noa¹,Magod Prerna²,Caspi Michal³,Loewenstein Shelly⁴⁵,Lahat Guy⁴⁵,Friedmann‐Morvinski Dinorah²,Kariv Revital³⁶,Rosin‐Arbesfeld Rina³,Zirkin Shahar¹,Ebenstein Yuval¹^ORCID

Affiliation:

1. School of Chemistry, Center for Nanoscience and Nanotechnology, Center for Light‐Matter Interaction, Raymond and Beverly Sackler Faculty of Exact SciencesTel Aviv University Tel Aviv Israel

2. Sagol School of Neuroscience, Department of Biochemistry and Molecular Biology, The George S. Wise Faculty of Life SciencesTel Aviv University Tel Aviv Israel

3. Department of Clinical Microbiology and Immunology, Sackler School of MedicineTel Aviv University Tel Aviv Israel

4. Department of SurgeryTel Aviv Sourasky Medical Center Tel Aviv Israel

5. Sackler School of MedicineTel Aviv University Tel Aviv Israel

6. Department of GastroenterologyTel Aviv Sourasky Medical Center Tel Aviv Israel

Funder

European Research Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32519